C12N 2501/35
Vasoactive intestinal peptide [vip]
Official title: Vasoactive intestinal peptide [VIP]; Pituitary adenylate cyclase activating polypeptide [PACAP]
C12N2501/35 (Vasoactive intestinal peptide [vip]) appears on 6 US grants and 20 published applications in this corpus.
Search patents in C12N- Granted patents
- 6
- Published applications
- 20
- Assignees
- 10
- Inventors
- 40
- Latest grant
- 24 Sep 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 2 |
| 2003 | 1 | 0 |
| 2004 | 0 | 4 |
| 2005 | 1 | 2 |
| 2006 | 0 | 4 |
| 2007 | 0 | 2 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Compositions and uses of vasoactive intestinal peptide (VIP) antagonists24 Sep 2024US 12,098,180 B2Emory University
- Methods and compositions for the rapid production of retinal pigmented epithelial cells from pluripotent cells4 Oct 2016US 9,458,428 B2The Regents of the University of California
- Composition for culturing mouse pluripotent stem cells20 Apr 2010US 7,700,352 B2Riken
- Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (PACAP)6 May 2008US 7,368,115 B2Stem Cell Therapeutics Inc.
- Production of tyrosine hydroxylase positive neurons18 Jan 2005US 6,844,312 B2Stem Cell Therapeutics Inc.
- Compositions and uses of vasoactive intestinal peptide (vip) antagonists17 Apr 2025US 2025/0122258 A1Emory University
- Compositions and uses of vasoactive intestinal peptide (vip) antagonists6 Jan 2022US 2022/0002372 A1Emory University
- Methods and Compositions for the Rapid Production of Retinal Pigmented Epithelial Cells from Pluripotent Cells25 Jun 2015US 2015/0175964 A1The Regents of the University of California
- Use Of Mesenchymal Stem Cells For The Improvement Of Affective And Cognitive Function17 Apr 2014US 2014/0105871 A1Ariel-University Research and Development Company Ltd.
- Endorphin Therapy Compositions and Methods5 May 2011US 2011/0104296 A1
Most cited
By later US patents
- Progenitor cells and methods and uses related thereto95US 6,610,535 B1ES Cell International PTE Ltd. · 2003
- Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (PACAP)16US 7,368,115 B2Stem Cell Therapeutics Inc. · 2008
- Production of tyrosine hydroxylase positive neurons10US 6,844,312 B2Stem Cell Therapeutics Inc. · 2005
- Composition for culturing mouse pluripotent stem cells4US 7,700,352 B2Riken · 2010
- Methods and compositions for the rapid production of retinal pigmented epithelial cells from pluripotent cells2US 9,458,428 B2The Regents of the University of California · 2016